Biochemical assays have demonstrated that the overexpression of DUOX2 in CRC cells results in a reduction of GSH-PX levels, whereas the knockout of DUOX2 leads to an elevation in GSH-PX content (Fig. 4d). The gene discussed is DUOX2; the disease is colorectal carcinoma.